3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Lymphoma, Large B-Cell, Diffuse
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, Mantle-Cell
5
Lymphoma, Follicular
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Breast Neoplasms
5
Prostatic Neoplasms
4
Multiple Myeloma
4
Lymphoma, T-Cell, Cutaneous
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Myeloid, Acute
4
Burkitt Lymphoma
4
Waldenstrom Macroglobulinemia
3
Sezary Syndrome
3
Recurrence
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms
3
Mycosis Fungoides
3
Lymphoma, Extranodal NK-T-Cell
3
Lymphoma
3
Leukemia, Hairy Cell
3
Leukemia
3
Hodgkin Disease
3
Head and Neck Neoplasms
3
Brain Neoplasms
3
Blast Crisis
3
Melanoma
2
Lymphoma, Large-Cell, Anaplastic
2
Interventions
Therapeutics
1
Interpersonal Psychotherapy
1
Ethanol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Alcoholism
×
Therapeutics
×
Clear all
NCT00851669
2013-07-16
MEADOW/Bridge
University of Rochester
Phase 2
Completed
91 enrolled